《新股消息》傳快手引10基投國際配售初步已錄足額認購 每手入場費11,616元
據《路透》旗下IFR報道,將於明日起招股的快手,今日接受機構投資者建簿認購,國際配售部分初步已錄得足額認購,並將引入10名基石投資者,包括新加坡主權基金GIC、貝萊德、淡馬錫、博裕資本及阿布達比投資局等,認購約24.5億美元等值股份。
報道引述銷售文件指,快手將發行超過3.65億股股份,佔公司擴大後股本約8.9%,香港公開發售部分佔2.5%,佔比最多可回撥至6%,集資規模達383.5億至420億元,計及超額配售權集資額最多達483億元,預期招股價介乎每股105至115元,每手100股入場費為約11,615.89元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.